SAMN02344105
External Id
Shanghai Laiyi Center for Biopharmaceuticals R&D, 800 Dong Chuan Road, Minhang, Shanghai, 200240, China
INSDC center name
2013-09-04T12:30:56.430Z
INSDC first public
2014-06-09T18:23:15.720Z
INSDC last update
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
Streptomyces sp. HCCB10043 produces lots of active compounds, such as A21978C, arylomycins, valistatin, bestatin and a new aminopeptidase inhibitor, 3-amino-2-hydroxy-4-phenylbutanoylvalylisoleucine. To further exploit this promising stain, the draft genome sequence was determined. It allows us to improve the targeted products by genetic manipulation, and provide a convenient way to learn the biosynthetic pathway of these known products and the potential capacity of HCCB10043 to produce new secondary metabolites.
description
Streptomyces sp. HCCB10043
http://purl.obolibrary.org/obo/NCBITaxon_1396518
organism
HCCB10043
strain
General Sample for Streptomyces sp. HCCB10043
title